A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19
NCT06147063 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 243
Last updated 2025-06-29
Summary
The purpose of this study is to characterize the safety and immunogenicity of AZD9838 and AZD6563 when administered as a single dose vaccination against SARS-CoV-2 in adults.
Conditions
Interventions
- BIOLOGICAL
-
AZD9838
Intramuscular (IM) injection.
- BIOLOGICAL
-
Licensed mRNA vaccine
Intramuscular (IM) injection.
- BIOLOGICAL
-
AZD6563
Intramuscular (IM) injection.
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-27
- Primary Completion
- 2024-04-30
- Completion
- 2025-03-27
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years
NCT07069309 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults
NCT04885361 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects
NCT04563702 ·Status: COMPLETED ·Phase: PHASE1
-
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
NCT04636697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
NCT05463068 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine
NCT04497298 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults
NCT04758962 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19
NCT04838847 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
NCT04816669 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021
NCT04728347 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older
NCT04762680 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults
NCT04380701 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of NVX-CoV2705
NCT07079670 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized
NCT05016934 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention
NCT04686773 ·Status: COMPLETED ·Phase: PHASE2
-
Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine
NCT04930003 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
NCT05682638 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)
NCT04760743 ·Status: COMPLETED ·Phase: PHASE1
-
COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222
NCT04864561 ·Status: COMPLETED ·Phase: PHASE3
-
AZD1222 Vaccine for the Prevention of COVID-19
NCT04540393 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)
NCT02180295 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine
NCT05636319 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
NCT04860258 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
NCT04756323 ·Status: UNKNOWN ·Phase: PHASE2